Trive Bearish on EUR/USD

0 comments

Trive Bearish on EUR/USD

A second Trump term may strengthen the USD and weaken the EUR, especially with a Republican Congress. Proposed tariffs, supply chain restrictions, and potential tax cuts would drive dollar gains and boost U.S. inflation, while pressuring EUR/USD toward parity by 2025. This scenario could force the ECB to cut rates to support eurozone growth.

EUR: Under pressures

The EUR is facing increased bearish pressures amid rising political and economic uncertainties in Europe, particularly with turmoil within Germany’s coalition government. The recent dissolution of Germany's SPD-Greens-FDP coalition adds volatility as Germany now faces a likely snap election early next year, potentially destabilizing both domestic policy and market confidence. Polls indicate a potential shift toward a CDU/CSU-led government, though the ascent of the AfD could further shake investor sentiment, keeping EUR-assets under pressure. Adding to this, the divergence between U.S. and European economic policies is widening.

 

In the U.S., anticipated inflationary effects of new fiscal stimulus and tariffs under the Trump administration are likely to slow Fed easing, bolstering USD strength, while the ECB may continue cutting rates to support a Eurozone economy facing increased recession risk. Additionally, the shifting geopolitical landscape pressures Europe, as a potential reduction in U.S. support for the Ukraine war would force Europe to bear more economic responsibility, making the euro less appealing to international investors. The EUR/USD rate spread has tilted in favor of the USD, especially as new U.S. tariffs on EU imports are expected to weaken the eurozone’s growth outlook further. These factors together reinforce a bearish view on the EUR, with pressures mounting for a weaker EUR/USD as markets adjust to Europe’s unique economic and political headwinds.

 

On the data front, focus will be on the latest ZEW data out of Germany and the preliminary Q3 GDP data out of the Eurozone. Also of interest would be speeches by the ECB members as well as the release of the minutes from the October ECB meeting.

 

USD: ‘Trump Trades’ continuing

The USD outlook remains strong, supported largely by the “Trump trade” following Donald Trump’s election as U.S. President, with his fiscal stimulus and protectionist policies bolstering the currency.

Trump’s plans for increased government spending and tariffs are expected to drive inflationary pressures, potentially slowing the Fed’s rate-cutting pace and supporting the USD. The Fed has adopted a cautious, data-dependent approach, acknowledging elevated inflation and a steady, albeit slightly moderating, labor market. This economic resilience aligns with a "soft landing" scenario, where the U.S. economy can sustain growth without falling into recession, reinforcing USD strength.

As markets focus on upcoming U.S. CPI and retail sales data, along with commentary from Fed officials, investors are looking for confirmation of the “Trump trade” thesis. Barring any major shocks, Trump’s economic policies are likely to remain the USD’s primary driver in the near term.

 

EUR/USD 4H Chart

 

Disclaimer

This material is provided for informational purposes only and does not constitute financial, investment, or other advice. The opinions expressed in this material are those of the author and do not necessarily reflect the views of Trive International. No opinion contained in this material constitutes a recommendation by Trive International or its author regarding any particular investment, transaction, or investment strategy. This material should not be relied upon in making any investment decision.

 

The information provided does not consider the individual investment objectives, financial situation, or needs of any specific investor. Investors should seek independent financial advice tailored to their individual circumstances before making any investment decisions. Trive International shall not be liable for any loss, damage, or injury arising directly or indirectly from the use of this information or from any action or decision taken as a result of using this material.

 

Trive International may or may not have a financial interest in the companies or securities mentioned. The value of investments may fluctuate, and investors may not get back the amount they originally invested. Past performance is not indicative of future results.

 

For more information about Trive International, please visit http://trive.com/int

 

Additional Information 

Investing involves risk, including the potential loss of principal. Diversification and asset allocation strategies do not ensure a profit or guarantee against loss. The content in this material is subject to change without notice and may become outdated or inaccurate over time. Trive International does not undertake any obligation to update the information in this material.

 

By accessing this material, you acknowledge and agree to the terms of this disclaimer. If you do not agree with these terms, please refrain from using this information.

댓글

No comments

댓글 남기기
Your Email Address Will Not Be Published.

Trive

TriveHub

TriveHub_LogoWhitev3
TriveHub, 금융 역량 강화의 시작 

저희의 포괄적인 금융 교육 플랫폼인 TriveHub를 탐험해 보세요. 시장 인사이트, 전문가 가이드, 프리미엄 콘텐츠가 함께 모여 여러분의 투자 여정을 형성합니다. 주식, 통화, 가상화폐 등 어떤 것이 관심을 끌든지, 우리는 여러분이 정보에 기반한 결정을 내릴 수 있도록 필요한 지식을 제공합니다.
모든 금융 상품은 마진 거래 시 자본에 높은 위험을 수반합니다.모든 투자자에게 적합하지 않으며 초기 예치금보다 더 많은 손실을 입을 수 있습니다. 관련된 위험을 완전히 이해하고 필요한 경우 독립적인 조언을 구하시기 바랍니다. 자세한 내용은 전체 위험 공시, 영업 약관, 개인정보 보호정책을 참조하십시오. 
로그인 기능 지원 및 신뢰할 수 있는 미디어 파트너가 사이트 사용량을 분석할 수 있도록 쿠키를 사용합니다. 쿠키를 활성화한 상태로 사이트를 탐색하면 전체 사이트 경험을 즐길 수 있습니다. 쿠키 사용에 동의하게 되며, 자세한 내용은 쿠키 정보를 참조하십시오.
이 웹사이트(trivehub.com)는 Trive International의 소유이며, Trive International Ltd.의 등록 상표입니다. Trive International Ltd.는 영국령 버진 아일랜드 금융 당국인 금융 서비스 위원회(FSC BVI)의 인가 및 규제를 받으며, 회사 번호 1728826 및 라이선스 번호 BVI SIBA/L/14/1066으로 등록되어 있습니다.

© 2024 Trivehub

Trivehub is operated by Trive International. The information on this site is for informational purposes only and does not constitute investment advice.